QuantuMDx Overview
- Year Founded
-
2008
- Status
-
Private
- Employees
-
98
- Latest Deal Type
-
Later Stage VC
- Latest Deal Amount
-
$9.9M
- Investors
-
12
QuantuMDx General Information
Description
Developer of life sciences monitoring tools intended to conduct a molecular diagnosis. The company's tools specialize in compressing a molecular diagnostics laboratory into a simple-to-use, portable, affordable device and can be used anywhere from remote rural settings to clinics and hospitals, enabling doctors to test, diagnose and give patients treatment options in one consultation.
Contact Information
Website
www.quantumdx.comCorporate Office
- Lugano Building
- 57 Melbourne Street
- Newcastle Upon Tyne NE1 2JQ
- England, United Kingdom
Corporate Office
- Lugano Building
- 57 Melbourne Street
- Newcastle Upon Tyne NE1 2JQ
- England, United Kingdom
QuantuMDx Timeline
QuantuMDx Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 11. Later Stage VC | 23-Nov-2022 | $9.9M | Completed | Generating Revenue | ||
| 10. Later Stage VC | 21-Oct-2021 | Completed | Generating Revenue | |||
| 9. Later Stage VC | 27-Jan-2020 | Completed | Generating Revenue | |||
| 8. Later Stage VC | 25-Jan-2019 | Completed | Generating Revenue | |||
| 7. Later Stage VC | 01-Dec-2017 | Completed | Generating Revenue | |||
| 6. Later Stage VC | 14-Dec-2016 | Completed | Startup | |||
| 5. Later Stage VC | 22-Dec-2015 | Completed | Startup | |||
| 4. Angel (individual) | 08-Dec-2014 | Completed | Startup | |||
| 3. Product Crowdfunding | 12-Feb-2014 | $18.1K | Completed | Startup | ||
| 2. Grant | 17-Oct-2013 | $1.6M | Completed | Startup |
QuantuMDx Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Ordinary | ||||||||
| Ordinary | ||||||||
| Ordinary | ||||||||
| Ordinary | ||||||||
| Ordinary | ||||||||
| Ordinary | ||||||||
| Ordinary | ||||||||
| Ordinary | ||||||||
| Ordinary | 16,026 | $0.011620 | $339.8 | $339.8 | 1x | $339.8 | 3.7% | |
| Ordinary | 35,821 | $0.011620 | $280.44 | $280.44 | 1x | $280.44 | 8.27% |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Opportunity Score
Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.
Exit Type
Evaluates the likelihood of a successful exit for investors, and the most likely exit type.
QuantuMDx Comparisons
Industry
Financing
Details
QuantuMDx Competitors (31)
One of QuantuMDx’s 31 competitors is Illumina, a Formerly VC-backed company based in San Diego, CA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Illumina | Formerly VC-backed | San Diego, CA | ||||
| Genomind | Venture Capital-Backed | King of Prussia, PA | ||||
| Autogenomics | Formerly VC-backed | Carlsbad, CA | ||||
| DNAe | Formerly VC-backed | London, United Kingdom | ||||
| OpGen | Formerly VC-backed | Rockville, MD |
QuantuMDx Patents
QuantuMDx Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| GB-202207655-D0 | The internet of life | Inactive | 25-May-2022 | ||
| GB-202202224-D0 | Methods, systems and devices for qpcr and array-based analysis of targets in a sample volume | Inactive | 18-Feb-2022 | ||
| EP-4479558-A1 | Methods, systems and devices for qpcr and array-based analysis of targets in a sample volume | Pending | 18-Feb-2022 | ||
| EP-4363107-A1 | Microfluidic device for concentrating target particles in a fluid sample using dielectrophoresis | Pending | 30-Jun-2021 | ||
| JP-2024530859-A | A microfluidic device that uses dielectrophoresis to concentrate target particles in a fluid sample | Pending | 30-Jun-2021 | B01L3/502761 |
QuantuMDx Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
QuantuMDx Investors (12)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Astrid Hill Investment | Venture Capital | Minority | ||
| British Business Bank | Lender/Debt Provider | Minority | ||
| Vita Spring IVD Fund | Venture Capital | Minority | ||
| Adjuvo | Venture Capital | Minority | ||
| 3B Future Health Fund | Venture Capital | Minority |
QuantuMDx Acquisitions (1)
QuantuMDx’s most recent deal was a Merger/Acquisition with Northgene. The deal was made on 01-Mar-2013.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Northgene | 01-Mar-2013 | Merger/Acquisition | Laboratory Services (Healthcare) |
Affiliates
Subsidiaries (1)
| Name | Industry | Location | Year Founded |
|---|---|---|---|
| Northgene | Deeside, United Kingdom | 1995 |
QuantuMDx FAQs
-
When was QuantuMDx founded?
QuantuMDx was founded in 2008.
-
Where is QuantuMDx headquartered?
QuantuMDx is headquartered in Newcastle Upon Tyne, United Kingdom.
-
What is the size of QuantuMDx?
QuantuMDx has 98 total employees.
-
What industry is QuantuMDx in?
QuantuMDx’s primary industry is Diagnostic Equipment.
-
Is QuantuMDx a private or public company?
QuantuMDx is a Private company.
-
What is the current valuation of QuantuMDx?
The current valuation of QuantuMDx is .
-
What is QuantuMDx’s current revenue?
The current revenue for QuantuMDx is .
-
How much funding has QuantuMDx raised over time?
QuantuMDx has raised $112M.
-
Who are QuantuMDx’s investors?
Astrid Hill Investment, British Business Bank, Vita Spring IVD Fund, Adjuvo, and 3B Future Health Fund are 5 of 12 investors who have invested in QuantuMDx.
-
Who are QuantuMDx’s competitors?
Illumina, Genomind, Autogenomics, DNAe, and OpGen are some of the 31 competitors of QuantuMDx.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »
